Pages that link to "Q26800996"
Jump to navigation
Jump to search
The following pages link to Clinical implications of the intrinsic molecular subtypes of breast cancer (Q26800996):
Displaying 50 items.
- Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting (Q26747792) (← links)
- Molecular subtypes and imaging phenotypes of breast cancer. (Q28069885) (← links)
- Breast cancer molecular subtypes: from TNBC to QNBC (Q28076805) (← links)
- BI-RADS 3-5 microcalcifications can preoperatively predict breast cancer HER2 and Luminal a molecular subtype (Q30358627) (← links)
- Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f Tumor-Initiating Population (Q33659361) (← links)
- Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. (Q33706962) (← links)
- The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer (Q36110285) (← links)
- Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer (Q36111215) (← links)
- Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy (Q36383626) (← links)
- Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer (Q36547919) (← links)
- Overview of Genetically Engineered Mouse Models of Distinct Breast Cancer Subtypes (Q36784065) (← links)
- ONE-CLASS DETECTION OF CELL STATES IN TUMOR SUBTYPES (Q36867680) (← links)
- Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer (Q37457902) (← links)
- Oestrogen receptor negativity in breast cancer: a cause or consequence? (Q37529397) (← links)
- Luminal B breast cancer: patterns of recurrence and clinical outcome (Q37662184) (← links)
- Epidemiology and survival outcome of breast cancer in a nationwide study. (Q37725545) (← links)
- Metastatic triple negative breast cancer: Optimizing treatment options, new and emerging targeted therapies (Q38641240) (← links)
- High expression of COX5B is associated with poor prognosis in breast cancer (Q38673586) (← links)
- Bevacizumab Modulation of the Interaction Between the MCF-7 Cell Line and the Chick Embryo Chorioallantoic Membrane. (Q38709589) (← links)
- Pooled Clustering of High-Grade Serous Ovarian Cancer Gene Expression Leads to Novel Consensus Subtypes Associated with Survival and Surgical Outcomes (Q38747875) (← links)
- Predictive biomarkers in the treatment of HER2-positive breast cancer: an ongoing challenge (Q38786102) (← links)
- Hereditary breast and ovarian cancer: new genes in confined pathways (Q38925408) (← links)
- Expression Profiling of Clinical Specimens Supports the Existence of Neural Progenitor-Like Stem Cells in Basal Breast Cancers (Q38952768) (← links)
- Advancement of mass spectrometry-based proteomics technologies to explore triple negative breast cancer. (Q39021766) (← links)
- FDG PET/CT Assesses the Risk of Femoral Pathological Fractures in Patients With Metastatic Breast Cancer (Q39122509) (← links)
- Human Tumor-Infiltrating Myeloid Cells: Phenotypic and Functional Diversity (Q39144794) (← links)
- Wnt signaling in triple-negative breast cancer. (Q39214992) (← links)
- Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma (Q39262474) (← links)
- Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups (Q39625095) (← links)
- Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer (Q40053251) (← links)
- MPZL1 forms a signalling complex with GRB2 adaptor and PTPN11 phosphatase in HER2-positive breast cancer cells (Q41050362) (← links)
- Papillotubular carcinoma with an invasive micropapillary carcinoma component of the breast, characterized by a rapid increase in size due to intra-tumoral hemorrhage: A case report. (Q41235051) (← links)
- Ancestry as a potential modifier of gene expression in breast tumors from Colombian women. (Q41498719) (← links)
- Correlation between c-Met and ALDH1 contributes to the survival and tumor-sphere formation of ALDH1 positive breast cancer stem cells and predicts poor clinical outcome in breast cancer (Q41659344) (← links)
- A pathways-based prediction model for classifying breast cancer subtypes (Q41709107) (← links)
- Revisiting the impact of age and molecular subtype on overall survival after radiotherapy in breast cancer patients (Q42282489) (← links)
- Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial (Q42497114) (← links)
- Genomic profiling of breast cancer in African-American women using MammaPrint. (Q42498238) (← links)
- HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial. (Q42506198) (← links)
- Incorporating Tumor Characteristics to the American Joint Committee on Cancer Breast Cancer Staging System (Q45134639) (← links)
- Challenges and Opportunities in Studying the Epidemiology of Ovarian Cancer Subtypes. (Q45933729) (← links)
- Endocrine sensitivity of estrogen receptor-positive breast cancer is negatively correlated with aspartate-β-hydroxylase expression (Q47097891) (← links)
- PRMDA: personalized recommendation-based MiRNA-disease association prediction (Q47114178) (← links)
- GSTT1, GSTP1, and GSTM1 genetic variants are associated with survival in previously untreated metastatic breast cancer (Q47123679) (← links)
- The influence of stage at diagnosis and molecular subtype on breast cancer patient survival: a hospital-based multi-center study. (Q47138958) (← links)
- Structural determinant of BST-2-mediated regulation of breast cancer cell motility: a role for cytoplasmic tail tyrosine residues (Q47155329) (← links)
- UBAP2L silencing inhibits cell proliferation and G2/M phase transition in breast cancer (Q47339607) (← links)
- IL-22 promotes the progression of breast cancer through regulating HOXB-AS5. (Q47372478) (← links)
- Molecular subtyping of breast cancer improves identification of both high and low risk patients. (Q47374603) (← links)
- Targeting bromodomain and extraterminal proteins in breast cancer (Q47385983) (← links)